EDGE MEDICAL-B (02675) has announced its allotment results. The company globally offered 27,722,200 H shares, with an over-allotment of 4,158,300 shares. The final number of shares offered under the Hong Kong public offering constituted 8.70% of the global offering (after the over-allotment), while the final number of shares offered under the international offering constituted 91.30% of the global offering (after the over-allotment). The final offer price was set at HK$43.24 per share, with net proceeds from the global offering amounting to approximately HK$1.117 billion. Each board lot consists of 100 shares, and the shares are expected to commence trading on the Stock Exchange at 9:00 a.m. on January 8, 2026. The Hong Kong public offering was oversubscribed by approximately 1091.94 times, and the international offering was oversubscribed by approximately 25.18 times.